Top Section/Ad
Top Section/Ad
Most recent
Disruptive US economic policy has not yet dented credit appetite
High yield investors nibble at IG names, as credit investors brace for ‘trillions’ unlocked from money market funds
Embattled utility makes final plea for court to sanction £3bn in emergency funding
Thames Water refinancing battle is an unedifying mess
More articles/Ad
More articles/Ad
More articles
-
-
If Fresenius Medical Care re-opened the European high yield bond market on September 8, the intervening three weeks without deals meant it needed re-opening again.
-
The European high yield market is willing to price deals again, if only for strong double-B names like HeidelbergCement and Fresenius Medical Care. But issuance will remain tough for the foreseeable future.
-
-
International bond issues from Asian companies remain firmly on hold, following a plummet in secondary prices last week that left already-bruised investors in a state of shock.
-
Two high yield bond issues this month, by HeidelbergCement and Fresenius Medical Care, have proved that investors will put a price on double-B bonds, but that still leaves many lower rated companies out in the cold and needing funds.